explore -WSS

explore

author：focus 2025-09-14 10:09:32 - browse：88388

Scanned cerebellum of a mouse brain, affected by Niemann-Pick Type C, shown in pink and teal — biotech coverage from STAT — The cerebellum of a mouse brain affected by Niemann-Pick Type C. Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health

About a decade ago, Tatiana Bremova-Ertl’s graduate adviser was studying an obscure, 1950s-era French vertigo drug, probing its effects on people with balance disorders, when she thought of another, very sick group of patients.

A graduate student and medical resident at the German Center for Vertigo and Balance Disorders, in Munich, Bremova-Ertl often saw patients with Niemann-Pick Type C, a rare, genetic disease that slowly kills neurons.

NPC has a range of manifestations. When symptoms appear in early childhood, it is often fatal before adulthood. When it manifests later, it can be milder. But it’s always degenerative and leads to a cluster of challenges: cognitive decline, difficulty with speech and swallowing, enlarged liver, low muscle tone, and, notably, difficulty with balance and muscle control. Researchers and a fervent group of parents were working to develop medicines, but little had yet worked.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： For Medicare Advantage, Democrats want stronger protections around AI

entertainment

WSS

KalVista pill reduced swelling 'attacks' caused by genetic disease

Sage hopes for a blockbuster in antidepressant now before FDA

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

Doctors' information doesn't help them choose wisely when sick

To avoid data mishandling cases, universities eye AI and other tools

Trump indictment: Who are the 'co

hotspot

explore

explore

Virginia high school admissions case could be legal follow

A disappointing year of Humira biosimilars

Dobbs anniversary: the lost opportunity of abortion as health care

‘Oppenheimer’ and the risks of AI in health care

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Sage hopes for a blockbuster in antidepressant now before FDA

BioMarin wins approval for gene therapy to treat hemophilia A

Mega Millions pot grows to $1.25 billion after no winner

Novavax promises a turnaround & Lilly roils the obesity market

PhRMA lawsuit over Medicare drug price negotiation tossed

hotspot

Key House Republican on health care plans exit from Congress

Adults seen as increasingly susceptible to measles

KalVista pill reduced swelling 'attacks' caused by genetic disease

Senators start work on Medicare physician payment reform

Trump indictment: Who are the 'co

The dental labor crisis is a moment of opportunity

entertainment

Wikipedia

entertainment

focus